OTCMKTS:PCHM PharmChem (PCHM) Stock Price, News & Analysis $3.91 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsHeadlinesShort InterestBuy This Stock About PharmChem Stock (OTCMKTS:PCHM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PharmChem alerts:Sign Up Key Stats Today's Range$3.91▼$3.9150-Day Range$2.97▼$3.9352-Week Range$2.85▼$3.95VolumeN/AAverage Volume1,792 shsMarket Capitalization$18.18 millionP/E Ratio12.22Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas. Read More Receive PCHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. Email Address PCHM Stock News HeadlinesPharmChem, Inc. (PCHM) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comPharmChem, Inc. (PCHM) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.July 5 at 2:00 AM | Paradigm Press (Ad)PharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comPharmChem considers strategic alternativesFebruary 3, 2025 | msn.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | gurufocus.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | prnewswire.comSee More Headlines PCHM Stock Analysis - Frequently Asked Questions How have PCHM shares performed this year? PharmChem's stock was trading at $3.06 at the beginning of the year. Since then, PCHM shares have increased by 27.8% and is now trading at $3.91. How were PharmChem's earnings last quarter? PharmChem Inc. (OTCMKTS:PCHM) issued its earnings results on Friday, May, 9th. The company reported $0.06 earnings per share (EPS) for the quarter. The company had revenue of $1.58 million for the quarter. How do I buy shares of PharmChem? Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/09/2025Today7/05/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolOTCMKTS:PCHM CIKN/A Webwww.pharmchek.com Phone(855) 458-4100Fax817-605-6400Employees170Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.32 Trailing P/E Ratio12.22 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.38 million Net Margins24.02% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.09 million Price / Sales2.99 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,650,000Free Float3,839,000Market Cap$18.18 million OptionableNot Optionable Beta0.77 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (OTCMKTS:PCHM) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
